.After antibody-drug conjugate (ADC) specialist Seagen was actually offered to Pfizer last year for ...
.On the heels of a phase 3 gain that stopped working to excite investors, Ironwood Pharmaceuticals i...
.Don't quit Monte Rosa Therapeutics right now. The Boston-based biotech is actually enjoying after s...
.Invite to this week's Chutes & Ladders, our summary of significant leadership hirings, firings a...
.Celebrating his firm's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the position ...
.AbbVie has actually gone back to the source of its antipsychotic goliath Vraylar looking for yet an...
.GenSight Biologics is full weeks off of losing amount of money. Once again. The biotech just posses...
.Monopar Rehabs is recuperating a medication from the scrap heap of AstraZeneca's unusual ailment pi...
.With brand new data out on Arcus Biosciences' experimental HIF-2a prevention, one group of experts ...
.After creating a genetics treatment partnership along with Dyno Rehabs in 2020, Roche is actually b...